Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation

von Rezvani, Andrew R., Storb, Rainer F.
Veröffentlicht 2008

Rituximab Resistance

von Rezvani, Andrew R., Maloney, David G.
Veröffentlicht 2011

Prevention of graft-vs.-host disease

von Rezvani, Andrew R., Storb, Rainer F.
Veröffentlicht 2012

Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes

von Rezvani, Andrew R., Sandmaier, Brenda M.
Veröffentlicht 2013

Inducible co-stimulator (ICOS) up-regulation on activated T-cells in chronic graft-vs.-host disease following dog-leukocyte-antigen-nonidentical hematopoietic cell transplantation:...

von Sato, Masahiko, Storb, Rainer, Loretz, Carol, Stone, Diane, Mielcarek, Marco, Sale, George E., Rezvani, Andrew R., Graves, Scott S.
Veröffentlicht 2013

Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study

von Multani, Ashrit, Allard, Libby S., Wangjam, Tamna, Sica, R. Alejandro, Epstein, David J., Rezvani, Andrew R., Ho, Dora Y.
Veröffentlicht in Blood Adv (2019)

Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20(+) B Cell Malignancies

von Granot, Noa, Rezvani, Andrew R., Pender, Barbara S., Storer, Barry E., Sandmaier, Brenda M., Storb, Rainer, Maloney, David G.
Veröffentlicht in Biol Blood Marrow Transplant (2020)

Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes

von Rezvani, Andrew R., McCune, Jeannine S., Storer, Barry E., Batchelder, Ami, Kida, Aiko, Deeg, H. Joachim, McDonald, George B.
Veröffentlicht 2013

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation

von Rezvani, Andrew R., Storer, Barry E., Guthrie, Katherine A., Schoch, H. Gary, Maloney, David G., Sandmaier, Brenda M., Storb, Rainer
Veröffentlicht in Biol Blood Marrow Transplant (2014)

Decreased serum albumin as a biomarker for severe acute graft-vs.-host disease after reduced-intensity allogeneic hematopoietic cell transplantation

von Rezvani, Andrew R., Storer, Barry E., Storb, Rainer F., Mielcarek, Marco, Maloney, David G., Sandmaier, Brenda M., Martin, Paul J., McDonald, George B.
Veröffentlicht 2011

Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation

von Muffly, Lori, Sheehan, Kevin, Armstrong, Randall, Jensen, Kent, Tate, Keri, Rezvani, Andrew R., Miklos, David, Arai, Sally, Shizuru, Judith, Johnston, Laura, Meyer, Everett, Weng, Wen-Kai, Laport, Ginna G., Negrin, Robert S., Strober, Sam, Lowsky, Robert
Veröffentlicht in Blood Adv (2018)

Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma

von Epperla, Narendranath, Ahn, Kwang Woo, Ahmed, Sairah, Jagasia, Madan, DiGilio, Alyssa, Devine, Steven M., Jaglowski, Samantha, Kennedy, Vanessa, Rezvani, Andrew R., Smith, Sonali M., Sureda, Anna, Fenske, Timothy S., Kharfan-Dabaja, Mohamed A., Armand, Phillipe, Hamadani, Mehdi
Veröffentlicht in J Hematol Oncol (2017)

Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using total lymphoid irradiation and anti-thymocyte globulin conditioning

von Rezvani, Andrew R., Kanate, Abraham S., Efron, Bradley, Chhabra, Saurabh, Kohrt, Holbrook E., Shizuru, Judith A., Laport, Ginna G., Miklos, David B., Benjamin, Jonathan E., Johnston, Laura J., Arai, Sally, Weng, Wen-Kai, Negrin, Robert S., Strober, Samuel, Lowsky, Robert
Veröffentlicht in Bone Marrow Transplant (2015)

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

von Scott, Bart L., Gooley, Ted A., Sorror, Mohamed L., Rezvani, Andrew R., Linenberger, Michael L., Grim, Jonathan, Sandmaier, Brenda M., Myerson, David, Chauncey, Thomas R., Storb, Rainer, Buxhofer-Ausch, Veronika, Radich, Jerald P., Appelbaum, Frederick R., Deeg, H. Joachim
Veröffentlicht 2012

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: A multicenter experience

von Rezvani, Andrew R., Norasetthada, Lalitha, Gooley, Ted, Sorror, Mohamed, Bouvier, Michelle E., Sahebi, Firoozeh, Agura, Edward, Chauncey, Thomas, Maziarz, Richard T., Maris, Michael, Shizuru, Judith, Bruno, Benedetto, Bredeson, Christopher, Lange, Thoralf, Yeager, Andrew, Sandmaier, Brenda M., Storb, Rainer F., Maloney, David G.
Veröffentlicht 2008

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

von Spinner, Michael A., Kennedy, Vanessa E., Tamaresis, John S., Lavori, Philip W., Arai, Sally, Johnston, Laura J., Meyer, Everett H., Miklos, David B., Muffly, Lori S., Negrin, Robert S., Rezvani, Andrew R., Shizuru, Judith A., Weng, Wen-Kai, Hoppe, Richard T., Strober, Samuel, Lowsky, Robert
Veröffentlicht in Blood Adv (2019)

Long-Term Outcomes of Patients with Persistent Indolent B-cell Malignancies Undergoing Nonmyeloablative Allogeneic Transplantation

von Cassaday, Ryan D., Storer, Barry E., Sorror, Mohamed L., Sandmaier, Brenda M., Guthrie, Katherine A., Maloney, David G., Rajendran, Joseph G., Pagel, John M., Flowers, Mary E., Green, Damian J., Rezvani, Andrew R., Storb, Rainer F., Press, Oliver W., Gopal, Ajay K.
Veröffentlicht in Biol Blood Marrow Transplant (2014)

Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT

von Ryan, Christine E., Sahaf, Bita, Logan, Aaron C., O’Brien, Susan, Byrd, John C., Hillmen, Peter, Brown, Jennifer R., Dyer, Martin J. S., Mato, Anthony R., Keating, Michael J., Jaglowski, Samantha, Clow, Fong, Rezvani, Andrew R., Styles, Lori, Coutre, Steven E., Miklos, David B.
Veröffentlicht in Blood (2016)

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

von Spinner, Michael A., Fernández-Viña, Marcelo, Creary, Lisa E., Quinn, Olivia, Elder, Linda, Arai, Sally, Johnston, Laura J., Meyer, Everett H., Miklos, David B., Muffly, Lori S., Negrin, Robert S., Shizuru, Judith A., Weng, Wen-Kai, Laport, Ginna G., Strober, Samuel, Lowsky, Robert, Rezvani, Andrew R.
Veröffentlicht in Blood Adv (2017)

Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial

von Fuchs, Ephraim J., O’Donnell, Paul V., Eapen, Mary, Logan, Brent, Antin, Joseph H., Dawson, Peter, Devine, Steven, Horowitz, Mary M., Horwitz, Mitchell E., Karanes, Chatchada, Leifer, Eric, Magenau, John M., McGuirk, Joseph P., Morris, Lawrence E., Rezvani, Andrew R., Jones, Richard J., Brunstein, Claudio G.
Veröffentlicht in Blood (2021)